The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.
暂无分享,去创建一个
S. Harthug | P. Simmonds | B. von der Lippe | L. Jarvis | H. Bell | K. Skaug | K. Hellum | A. Maeland | S. Ritland | B. Myrvang | N. Raknerud | A. Hawkins
[1] P. Simmonds,et al. Patterns of Hepatitis G Viraemia and Liver Disease in Haemophiliacs Previously Exposed to Non-virus Inactivated Coagulation Factor Concentrates , 1998, Thrombosis and Haemostasis.
[2] J. Rakela,et al. Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses , 1997, Journal of virology.
[3] M. Houghton,et al. Effects of interferon treatment on the antiviral T‐cell response in hepatitis C virus genotype 1b‐ and genotype 2c‐infected patients , 1997, Hepatology.
[4] T. Morishima,et al. Hepatitis G infection. , 1997, The New England journal of medicine.
[5] M. Clementi,et al. Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis. , 1997, Journal of hepatology.
[6] H. Okamoto,et al. Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the co‐infection , 1997, Journal of medical virology.
[7] P. Marcellin,et al. Influence of Hepatitis G Virus Infection on the Severity of Liver Disease and Response to Interferon- in Patients with Chronic Hepatitis C , 1997, Annals of Internal Medicine.
[8] X. Forns,et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. , 1997, Journal of hepatology.
[9] R. Wesley,et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.
[10] H. Margolis,et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. , 1997, The New England journal of medicine.
[11] S. Iino,et al. Effect of interferon therapy on RNA of GB virus C in the patients with chronic hepatitis who were co-infected with hepatitis C virus , 1997 .
[12] I. Kay,et al. LOW PREVALENCE OF HEPATITIS G VIRAEMIA IN HAEMOPHILIA PATIENTS IN AUSTRALIA , 1997, British journal of haematology.
[13] P. Simmonds,et al. The clinical significance of the detection of hepatitis GBV‐C RNA in the serum of patients with fulminant, presumed viral, hepatitis , 1997, Journal of viral hepatitis.
[14] J. Tran van Nhieu,et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. , 1997, Gastroenterology.
[15] S. Harthug,et al. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. , 1997, Scandinavian journal of infectious diseases.
[16] P. Simmonds,et al. Infection with hepatitis G virus among recipients of plasma products , 1996, The Lancet.
[17] T. Berg,et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. , 1996, Journal of hepatology.
[18] E. Tanaka,et al. Effect of Hepatitis G Virus Infection on Chronic Hepatitis C , 1996, Annals of Internal Medicine.
[19] M. Biasin,et al. Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection , 1996, The Lancet.
[20] H. Margolis,et al. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.
[21] Ding‐Shinn Chen,et al. GBV-C in the aetiology of fulminant hepatitis , 1996, The Lancet.
[22] T. Pilot‐Matias,et al. Sequence and genomic organization of GBV‐C: A novel member of the flaviviridae associated with human non‐A‐E hepatitis , 1996, Journal of medical virology.
[23] S. Mishiro,et al. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.
[24] T. Pilot‐Matias,et al. Origin of GB-hepatitis viruses , 1995, The Lancet.
[25] T. Pilot‐Matias,et al. Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.
[26] P. Simmonds,et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. , 1995, The Journal of general virology.
[27] P. Simmonds,et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.
[28] P. Simmonds,et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users , 1990, The Lancet.
[29] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.